FIM
CCXI

Freedom Investment Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Freedom Investment Management’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,215
Closed -$261K – 923
2020
Q4 		$261K Buy
+4,215
New +$241K 0.03% 504

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Freedom Investment Management's CCXI Position: Q1 2021 in Review

Freedom Investment Management sold out of ChemoCentryx, Inc. (CCXI) in Q1 2021, closing a stake of 4,215 shares — an estimated $261K sold.

Freedom Investment Management first reported a position in CCXI in Q4 2020 and held it in 1 quarter. The position peaked at $261K in Q4 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • Freedom Investment Management reported no remaining ChemoCentryx, Inc. position as of Q1 2021 after selling out during the quarter.
  • Freedom Investment Management sold 4,215 ChemoCentryx, Inc. shares in Q1 2021, an estimated $261K.
  • Freedom Investment Management first reported a position in ChemoCentryx, Inc. in Q4 2020 and held it in 1 quarter.
  • Freedom Investment Management's ChemoCentryx, Inc. position peaked at $261K in Q4 2020.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Freedom Investment Management's 13F filing for Q1 2021, filed 14 May 2021.